2026 NURS 5334 Advanced pharmacology for NP Exam 2
2026 NURS 5334 Advanced pharmacology for NP Exam 2
,2026 NURS 5334 Advanced pharmacology for NP Exam 2
2026 NURS 5334 Advanced pharmacology for NP Exam 2
,A 68-year-old woman presents with hypertension and BP
of 152-158/92-96 mm Hg documented over 2 months on
three different occasions. Electrocardiogram (ECG) and
creatinine are normal, and she has no proteinuria. Clinical
findings include the following: BMI 26.4 kg/m2; no S3,
S4, or murmur; and point of maximal impulse at fifth
intercostal space, mid-clavicular line. Which of the
following represents the best intervention?
A. Initiate therapy with metoprolol.
B. Initiate therapy with hydrochlorothiazide.
C. Initiate therapy with methyldopa.
D. Continue to monitor BP, and start drug therapy if
evidence of target organ damage.
, B
The most important long-term goal of treating
hypertension is to:
A. strive to reach recommended numeric
BP measurement.
B. avoid disease-related target organ damage.
C. develop a plan of care with minimal adverse effects.
D. treat concomitant health problems often noted in
the person with this condition.
B
2026 NURS 5334 Advanced pharmacology for NP Exam 2
,2026 NURS 5334 Advanced pharmacology for NP Exam 2
2026 NURS 5334 Advanced pharmacology for NP Exam 2
,A 68-year-old woman presents with hypertension and BP
of 152-158/92-96 mm Hg documented over 2 months on
three different occasions. Electrocardiogram (ECG) and
creatinine are normal, and she has no proteinuria. Clinical
findings include the following: BMI 26.4 kg/m2; no S3,
S4, or murmur; and point of maximal impulse at fifth
intercostal space, mid-clavicular line. Which of the
following represents the best intervention?
A. Initiate therapy with metoprolol.
B. Initiate therapy with hydrochlorothiazide.
C. Initiate therapy with methyldopa.
D. Continue to monitor BP, and start drug therapy if
evidence of target organ damage.
, B
The most important long-term goal of treating
hypertension is to:
A. strive to reach recommended numeric
BP measurement.
B. avoid disease-related target organ damage.
C. develop a plan of care with minimal adverse effects.
D. treat concomitant health problems often noted in
the person with this condition.
B
